Lin-Pierre Zhao

19PUBLICATIONS
151CO-AUTHORS
Innate immunityMolecular targetsHaematological tumoursGene and molecular therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Paul Breillat, Francesco Carbone, Emilie Lereclus

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Apr 18, 2025
Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine.

Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette

|Jun 14, 2024
MOSAIC: An Artificial Intelligence-Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare Cancers.

Saverio D'Amico, Lorenzo Dall'Olio, Cesare Rollo

|May 09, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.

Cristina Astrid Tentori, Caterina Gregorio, Marie Robin

Pageof 4

Frequent Collaborators

13 joint publications

Lionel Ades

6 joint publications

Nicolas Dulphy

5 joint publications

Arsene Mekinian

5 joint publications

Karl Balabanian